ArticlePerspectives in medicinal chemistry2007

Lead Optimization in Discovery Drug Metabolism and Pharmacokinetics/Case study: The Hepatitis C Virus (HCV) Protease Inhibitor SCH 503034.

K-C Cheng et al.PubMed ↗Full text ↗

No numbers read from the abstract.